World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
102
Citations
45450
World Ranking
7567
National Ranking
3945

Overview

Brent L. Wood is affiliated with the University of Washington in the United States. Their research is primarily situated in the field of Medicine, with a particular focus on subfields including Public Health, Environmental and Occupational Health, Hematology, Pediatrics, Perinatology and Child Health, Genetics, and Oncology.

The scientist has contributed extensively to topics related to leukemia and childhood cancer, with principal areas of work encompassing:

  • Acute Lymphoblastic Leukemia research
  • Acute Myeloid Leukemia Research
  • Childhood Cancer Survivors' Quality of Life
  • Chronic Myeloid Leukemia Treatments
  • Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • CAR-T cell therapy research

The publication history of Brent L. Wood includes frequent appearances in several key scientific journals, predominantly:

  • Blood
  • Journal of Clinical Oncology
  • Leukemia
  • Blood Advances
  • Haematologica

Some recent notable papers authored or co-authored by Brent L. Wood are:

  • "The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms," 2022, published in Leukemia
  • "The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms," 2022, published in Leukemia
  • "2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party," 2021, published in Blood
  • "The genomic landscape of pediatric acute lymphoblastic leukemia," 2022, published in Nature Genetics
  • "Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia," 2020, published in Journal of Clinical Oncology

Throughout their career, Brent L. Wood has collaborated frequently with several researchers, including:

  • Mignon L. Loh
  • Meenakshi Devidas
  • Elizabeth A. Raetz
  • Stephen P. Hunger
  • Andrew J. Carroll

Best Publications

  • CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients

    Cameron J. Turtle;Laïla Aïcha Hanafi;Carolina Berger;Theodore A. Gooley

  • The genetic basis of early T-cell precursor acute lymphoblastic leukaemia

    Jinghui Zhang;Li Ding;Linda Holmfeldt;Gang Wu

  • Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia

    Hagop M Kantarjian;Anthony Stein;Nicola Gökbuget;Adele K. Fielding

  • Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies.

    Colin C. Pritchard;Evan Kroh;Brent Wood;Jason D. Arroyo

  • Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor–modified T cells

    Cameron J. Turtle;Cameron J. Turtle;Laila-Aicha Hanafi;Carolina Berger;Carolina Berger;Michael Hudecek

  • Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells.

    Brian G. Till;Brian G. Till;Michael C. Jensen;Jinjuan Wang;Eric Y. Chen

  • An Official American Thoracic Society Clinical Practice Guideline: The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis in Interstitial Lung Disease

    Keith C. Meyer;Ganesh Raghu;Robert P. Baughman;Kevin K. Brown

  • Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party.

    Gerrit J. Schuurhuis;Michael Heuser;Sylvie Freeman;Marie Christine Béne

  • The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia

    Yu Liu;John Easton;Ying Shao;Jamie Maciaszek

  • Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist.

    W. Conrad Liles;W. Conrad Liles;Hal E. Broxmeyer;Hal E. Broxmeyer;Elin Rodger;Elin Rodger;Brent Wood;Brent Wood

  • The genomic landscape of hypodiploid acute lymphoblastic leukemia

    Linda Holmfeldt;Lei Wei;Ernesto Diaz-Flores;Michael Walsh

  • Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor–Modified T Cells After Failure of Ibrutinib

    Cameron J. Turtle;Kevin A. Hay;Laïla-Aïcha Hanafi;Daniel Li

  • Using synthetic templates to design an unbiased multiplex PCR assay

    Christopher S. Carlson;Ryan O. Emerson;Anna M. Sherwood;Cindy Desmarais

  • Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations

    Brent L. Wood;Donald F. Gibson;Jonathan F. Tait

  • Unmetabolized Folic Acid in Plasma Is Associated with Reduced Natural Killer Cell Cytotoxicity among Postmenopausal Women

    Aron M. Troen;Breeana Mitchell;Breeana Mitchell;Bess Sorensen;Mark H. Wener

  • Identification of a human heme exporter that is essential for erythropoiesis.

    John G. Quigley;Zhantao Yang;Mark T. Worthington;John D. Phillips

  • Impact of Pretransplantation Minimal Residual Disease, As Detected by Multiparametric Flow Cytometry, on Outcome of Myeloablative Hematopoietic Cell Transplantation for Acute Myeloid Leukemia

    Roland B. Walter;Ted A. Gooley;Brent L. Wood;Filippo Milano

  • 2021 Update Measurable Residual Disease in Acute Myeloid Leukemia: European LeukemiaNet Working Party Consensus Document.

    Michael Heuser;Sylvie D Freeman;Gert J Ossenkoppele;Francesco Buccisano

  • PAX5 -driven subtypes of B-progenitor acute lymphoblastic leukemia

    Zhaohui Gu;Michelle L. Churchman;Kathryn G. Roberts;Ian Moore

  • Association of Minimal Residual Disease With Clinical Outcome in Pediatric and Adult Acute Lymphoblastic Leukemia: A Meta-analysis.

    Donald A. Berry;Shouhao Zhou;Howard Higley;Lata Mukundan

Frequent Co-Authors

Mignon L. Loh
Mignon L. Loh University of California, San Francisco
Stephen P. Hunger
Stephen P. Hunger University of Pennsylvania
Meenakshi Devidas
Meenakshi Devidas St. Jude Children's Research Hospital
Elizabeth A. Raetz
Elizabeth A. Raetz New York University
William L. Carroll
William L. Carroll New York University
Naomi J. Winick
Naomi J. Winick The University of Texas Southwestern Medical Center
Frederick R. Appelbaum
Frederick R. Appelbaum Fred Hutchinson Cancer Research Center
Michael J. Borowitz
Michael J. Borowitz Johns Hopkins University
Nyla A. Heerema
Nyla A. Heerema The Ohio State University
Elihu H. Estey
Elihu H. Estey University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career doesn’t always mean attending traditional, on-campus programs. Many students choose flexible and affordable pathways through online degrees, especially in nursing and healthcare. For those seeking a doctoral credential, an online phd nursing program can help advance research skills and open doors to leadership positions in the profession.

Registered nurses looking to enhance their qualifications can consider rn to bsn online programs, which allow working nurses to earn a bachelor’s degree while maintaining their current jobs. Similarly, individuals from non-nursing backgrounds can pursue direct entry online msn programs for a fast-track route into advanced nursing roles without a prior nursing degree.

For applicants focused on accessibility, it’s helpful to research the easiest bsn program to get into for a smoother admission process. With so many flexible online options available, students can find a program that matches their academic goals and lifestyle, making a healthcare career more accessible than ever.

Best Scientists Citing Brent L. Wood

Trending Scientists